Leveraging profound expertise in
international (ISO) and United States Food and Drug Administration (FDA)
medical device regulations, eToxLab offers comprehensive preclinical
testing support for diverse therapeutic sectors, including orthopedics,
dentistry, ophthalmology, cardiovascular, respiratory, and personal protective
equipment (PPEs).
Our core competency lies in
rigorous biocompatibility assessments adhering to the stringent ISO 10993
standards. As an OECD Good Laboratory Practice (GLP) certified and ISO 17025
accredited laboratory, eToxLab generates high-quality data consistently
accepted by regulatory bodies worldwide, including the USFDA (510(k) and PMA
submissions), the European Union (CE Marking), and others.
Our esteemed clientele encompasses national and international companies spanning India, the United Kingdom, France, the United States, Canada, Brazil, Malaysia, Germany, Australia, China, Norway, Saudi Arabia, Thailand, Indonesia, Switzerland, Japan, and beyond.
Buehler Sensitization MethodGuinea Pig Maximisation Test (Magnusson-Kligman)
Local Lymph Node Assay (LLNA) Acute
Sub-acute
Sub-chronic
Chronic Hemolysis Test
Partial Thromboplastin Time (PTT)
Complement Activation (C3a & SC5b-9)
Platelet Aggregation / Activation
Leukocyte Activation Test
Haematology Test Intramuscular
Subcutaneous
Bone In-vitro Biological Reactivity Tests
In-vivo Biological Reactivity Tests Bacterial Reverse Mutation (AMES) Test
Mouse Lymphoma Assay
In-vitro and In-vivo Micronucleus Test
In-vitro and In-vivo Chromosomal Aberration Biological Evaluation Plan
Toxicological Risk Assessment
Biological Evaluation Report ISO 10993
ASTM
US FDA
AAMI
Product-Specific ISO Guidelines
Product-Specific US FDA Guidance Documents
Pharmacopoeia (USP / BP / IP)
0 comments:
Post a Comment
Please do not enter any spam link in the comment box.